Moog C - Search Results

1

HIV-1 replication in Langerhans and interstitial dendritic cells is inhibited by neutralizing and Fc-mediated inhibitory antibodies.

Peressin M, Holl V, Schmidt S, Decoville T, Mirisky D, Lederle A, Delaporte M, Xu K, Aubertin AM, Moog C. Peressin M, et al. Among authors: moog c. J Virol. 2011 Jan;85(2):1077-85. doi: 10.1128/JVI.01619-10. Epub 2010 Nov 17. J Virol. 2011. PMID: 21084491 Free PMC article.

2

Bicyclic imidazo derivatives, a new class of highly selective inhibitors for the human immunodeficiency virus type 1.

Moog C, Wick A, Le Ber P, Kirn A, Aubertin AM. Moog C, et al. Antiviral Res. 1994 Aug;24(4):275-88. doi: 10.1016/0166-3542(94)90075-2. Antiviral Res. 1994. PMID: 7993073

3

Sodium valproate, an anticonvulsant drug, stimulates human immunodeficiency virus type 1 replication independently of glutathione levels.

Moog C, Kuntz-Simon G, Caussin-Schwemling C, Obert G. Moog C, et al. J Gen Virol. 1996 Sep;77 ( Pt 9):1993-9. doi: 10.1099/0022-1317-77-9-1993. J Gen Virol. 1996. PMID: 8810995

4

Neutralization of primary human immunodeficiency virus type 1 isolates: a study of parameters implicated in neutralization in vitro.

Moog C, Spenlehauer C, Fleury H, Heshmati F, Saragosti S, Letourneur F, Kirn A, Aubertin AM. Moog C, et al. AIDS Res Hum Retroviruses. 1997 Jan 1;13(1):19-27. doi: 10.1089/aid.1997.13.19. AIDS Res Hum Retroviruses. 1997. PMID: 8989423

5

Autologous and heterologous neutralizing antibody responses following initial seroconversion in human immunodeficiency virus type 1-infected individuals.

Moog C, Fleury HJ, Pellegrin I, Kirn A, Aubertin AM. Moog C, et al. J Virol. 1997 May;71(5):3734-41. doi: 10.1128/JVI.71.5.3734-3741.1997. J Virol. 1997. PMID: 9094648 Free PMC article.

6

Protection of SIVmac-infected macaque monkeys against superinfection by a simian immunodeficiency virus expressing envelope glycoproteins of HIV type 1.

Dunn CS, Hurtrel B, Beyer C, Gloeckler L, Ledger TN, Moog C, Kieny MP, Mehtali M, Schmitt D, Gut JP, Kirn A, Aubertin AM. Dunn CS, et al. Among authors: moog c. AIDS Res Hum Retroviruses. 1997 Jul 20;13(11):913-22. doi: 10.1089/aid.1997.13.913. AIDS Res Hum Retroviruses. 1997. PMID: 9223407

7

Study of the V3 loop as a target epitope for antibodies involved in the neutralization of primary isolates versus T-cell-line-adapted strains of human immunodeficiency virus type 1.

Spenlehauer C, Saragosti S, Fleury HJ, Kirn A, Aubertin AM, Moog C. Spenlehauer C, et al. Among authors: moog c. J Virol. 1998 Dec;72(12):9855-64. doi: 10.1128/JVI.72.12.9855-9864.1998. J Virol. 1998. PMID: 9811721 Free PMC article.

8

Oxysterols, but not cholesterol, inhibit human immunodeficiency virus replication in vitro.

Moog C, Aubertin AM, Kirn A, Luu B. Moog C, et al. Antivir Chem Chemother. 1998 Nov;9(6):491-6. doi: 10.1177/095632029800900605. Antivir Chem Chemother. 1998. PMID: 9865387

9

Generation of CD8+ T cell-generated suppressor factor and beta-chemokines by targeted iliac lymph node immunization in rhesus monkeys challenged with SHIV-89.6P by the rectal route.

Aubertin AM, Le Grand R, Wang Y, Beyer C, Tao L, Neildez O, Barré-Sinoussi F, Hurtrel B, Moog C, Lehner T, Girard M. Aubertin AM, et al. Among authors: moog c. AIDS Res Hum Retroviruses. 2000 Mar 1;16(4):381-92. doi: 10.1089/088922200309269. AIDS Res Hum Retroviruses. 2000. PMID: 10716376

10

Antibody-mediated neutralization of primary human immunodeficiency virus type 1 isolates: investigation of the mechanism of inhibition.

Spenlehauer C, Kirn A, Aubertin AM, Moog C. Spenlehauer C, et al. Among authors: moog c. J Virol. 2001 Mar;75(5):2235-45. doi: 10.1128/JVI.75.5.2235-2245.2001. J Virol. 2001. PMID: 11160727 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

135 results

Search Page